• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A case of chronic eosinophilic pneumonia successfully treated with mepolizumab.

作者信息

To Masako, Kono Yuta, Yamawaki Satoshi, Soeda Seiko, Katsube Otohiro, Kishi Hirohisa, To Yasuo

机构信息

Department of Allergy and Respiratory Medicine, Fraternity Memorial Hospital, Yokoami, Sumida, Tokyo, Japan; Department of Laboratory Medicine, Dokkyo Medical University, Saitama Medical Center, Minami-Koshigaya, Koshigaya City, Saitama, Japan.

Department of Allergy and Respiratory Medicine, Fraternity Memorial Hospital, Yokoami, Sumida, Tokyo, Japan.

出版信息

J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1746-1748.e1. doi: 10.1016/j.jaip.2018.06.017. Epub 2018 Jul 7.

DOI:10.1016/j.jaip.2018.06.017
PMID:30201098
Abstract
摘要

相似文献

1
A case of chronic eosinophilic pneumonia successfully treated with mepolizumab.1例用美泊利单抗成功治疗的慢性嗜酸性粒细胞性肺炎病例。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1746-1748.e1. doi: 10.1016/j.jaip.2018.06.017. Epub 2018 Jul 7.
2
Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.一名慢性嗜酸性粒细胞性肺炎患者接受抗白细胞介素5抗体的长期治疗
J Investig Allergol Clin Immunol. 2020 Apr 24;30(2):154-155. doi: 10.18176/jiaci.0468. Epub 2019 Nov 28.
3
Mepolizumab in the treatment of severe eosinophilic asthma: Results from a physician in the field.美泊利珠单抗治疗重度嗜酸性粒细胞性哮喘：一位临床医生的治疗结果
Ann Allergy Asthma Immunol. 2018 Jul;121(1):121-123. doi: 10.1016/j.anai.2018.04.016. Epub 2018 Apr 21.
4
Benralizumab as initial treatment for chronic eosinophilic pneumonia.贝那利珠单抗作为慢性嗜酸性粒细胞性肺炎的初始治疗药物。
Allergol Int. 2021 Jan;70(1):140-142. doi: 10.1016/j.alit.2020.07.005. Epub 2020 Aug 14.
5
Mepolizumab use: Post-approval academic practice experience.美泊利单抗的使用：批准后学术实践经验
Ann Allergy Asthma Immunol. 2018 Jul;121(1):126-128. doi: 10.1016/j.anai.2018.04.001. Epub 2018 Apr 10.
6
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.重度嗜酸性粒细胞性哮喘：从白细胞介素-5的致病作用到美泊利珠单抗的治疗作用
Drug Des Devel Ther. 2017 Oct 30;11:3137-3144. doi: 10.2147/DDDT.S150656. eCollection 2017.
7
Treatment for severe eosinophilic asthma-consistent effect of anti-interleukin-5 antibodies?重度嗜酸性粒细胞性哮喘的治疗——抗白细胞介素-5抗体的一致疗效？
Lancet. 2016 Oct 29;388(10056):2059-2060. doi: 10.1016/S0140-6736(16)31537-9. Epub 2016 Sep 5.
8
Efficacy of Mepolizumab Extended Interval Dosing for 2 Asthmatic Patients With Chronic Eosinophilic Pneumonia.美泊利单抗延长给药间隔对2例慢性嗜酸性粒细胞性肺炎哮喘患者的疗效
J Investig Allergol Clin Immunol. 2021 Oct 25;31(5):459-460. doi: 10.18176/jiaci.0671. Epub 2021 Jan 27.
9
Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab.使用贝那利珠单抗成功治疗复发性慢性嗜酸性粒细胞性肺炎。
Ann Allergy Asthma Immunol. 2021 Jun;126(6):726-727. doi: 10.1016/j.anai.2021.02.016. Epub 2021 Feb 24.
10
Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience.美泊利单抗治疗不适合使用奥马珠单抗的重度嗜酸性粒细胞性哮喘青少年：一个中心的早期临床经验
J Asthma. 2020 May;57(5):521-524. doi: 10.1080/02770903.2019.1579833. Epub 2019 Feb 22.

引用本文的文献

1
The management of type 2 inflammatory respiratory diseases: a Chinese expert consensus [2024].2型炎症性呼吸道疾病的管理：中国专家共识[2024年]
J Thorac Dis. 2025 Apr 30;17(4):1807-1831. doi: 10.21037/jtd-2024-2092. Epub 2025 Mar 25.
2
The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?美泊利珠单抗用于特发性慢性嗜酸性粒细胞性肺炎长期治疗的临床问题；我们应该使用美泊利珠单抗多长时间？
Respir Med Case Rep. 2024 Nov 13;52:102142. doi: 10.1016/j.rmcr.2024.102142. eCollection 2024.
3
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review.
特发性慢性嗜酸性粒细胞肺炎中的单克隆抗体：范围综述。
BMC Pulm Med. 2024 Feb 8;24(1):74. doi: 10.1186/s12890-024-02868-3.
4
Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia.病例报告：美泊利珠单抗治疗特发性慢性嗜酸性粒细胞肺炎。
F1000Res. 2023 Sep 5;12:337. doi: 10.12688/f1000research.130939.2. eCollection 2023.
5
Idiopathic Chronic Eosinophilic Pneumonia Evolving to Pulmonary Fibrosis: A Retrospective Analysis.特发性慢性嗜酸性粒细胞性肺炎演变为肺纤维化：一项回顾性分析。
Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(2):e2022020. doi: 10.36141/svdld.v39i2.12656. Epub 2022 Jun 29.
6
Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series.抗白细胞介素-5药物治疗特发性慢性嗜酸性粒细胞性肺炎：病例系列
J Asthma Allergy. 2022 Feb 9;15:169-177. doi: 10.2147/JAA.S343272. eCollection 2022.
7
Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.美泊利单抗和度普利尤单抗替代全身糖皮质激素治疗慢性嗜酸性粒细胞性肺炎和变应性支气管肺曲霉病——病例系列，阿尔穆萨专科医院
Respir Med Case Rep. 2021 Oct 1;34:101520. doi: 10.1016/j.rmcr.2021.101520. eCollection 2021.
8
Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance.美泊利珠单抗：一种用于糖皮质激素不耐受的特发性慢性嗜酸性粒细胞性肺炎的替代疗法。
Drugs Context. 2020 Aug 18;9. doi: 10.7573/dic.2020-5-3. eCollection 2020.
9
Possible Mechanisms of Eosinophil Accumulation in Eosinophilic Pneumonia.嗜酸性粒细胞性肺炎中嗜酸性粒细胞聚集的可能机制。
Biomolecules. 2020 Apr 21;10(4):638. doi: 10.3390/biom10040638.
10
Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.特发性慢性嗜酸性粒细胞性肺炎中美泊利单抗的真实生活研究。
Lung. 2020 Apr;198(2):355-360. doi: 10.1007/s00408-020-00336-3. Epub 2020 Feb 12.